Jonathan M Nugent - Net Worth and Insider Trading

Jonathan M Nugent Net Worth

The estimated net worth of Jonathan M Nugent is at least $3,254 dollars as of 2024-06-24. Jonathan M Nugent is the VP Corp Communications of BioCryst Pharmaceuticals Inc and owns about 508 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $3,254. Details can be seen in Jonathan M Nugent's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan M Nugent has not made any transactions after 2007-07-31 and currently still holds the listed stock(s).

Transaction Summary of Jonathan M Nugent

To

Jonathan M Nugent Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jonathan M Nugent owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .

Click here to see the complete history of Jonathan M Nugent’s form 4 insider trades.

Insider Ownership Summary of Jonathan M Nugent

Ticker Comapny Transaction Date Type of Owner
BCRX BioCryst Pharmaceuticals Inc 2007-07-31 VP Corp Communications

Jonathan M Nugent Latest Holdings Summary

Jonathan M Nugent currently owns a total of 1 stock. Jonathan M Nugent owns 508 shares of BioCryst Pharmaceuticals Inc (BCRX) as of July 31, 2007, with a value of $3,254.

Latest Holdings of Jonathan M Nugent

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2007-07-31 508 6.41 3,254

Holding Weightings of Jonathan M Nugent


Jonathan M Nugent Form 4 Trading Tracker

According to the SEC Form 4 filings, Jonathan M Nugent has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 285 shares on July 31, 2007, which cost Jonathan M Nugent around $2,009.

Insider Trading History of Jonathan M Nugent

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jonathan M Nugent Trading Performance

GuruFocus tracks the stock performance after each of Jonathan M Nugent's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan M Nugent is -10.8%. GuruFocus also compares Jonathan M Nugent's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan M Nugent within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jonathan M Nugent's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jonathan M Nugent

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.93 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.06 LIMIT LIMIT LIMIT LIMIT LIMIT

Jonathan M Nugent Ownership Network

Ownership Network List of Jonathan M Nugent

No Data

Ownership Network Relation of Jonathan M Nugent

Insider Network Chart

Jonathan M Nugent Owned Company Details

What does BioCryst Pharmaceuticals Inc do?

Who are the key executives at BioCryst Pharmaceuticals Inc?

Jonathan M Nugent is the VP Corp Communications of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .

BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary

Over the past 18 months, Jonathan M Nugent made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 70,000 shares made by Jon P Stonehouse , a net purchase of 23,000 shares made by Helen M. Thackray , and a net sale of 8,689 shares made by Machelle Sanders .

In summary, during the past 3 months, insiders sold 11,387 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 183,601 shares, with a net purchase of 172,214 shares. During the past 18 months, 135,253 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 48,348 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioCryst Pharmaceuticals Inc Insider Transactions

No Available Data

Jonathan M Nugent Mailing Address

Above is the net worth, insider trading, and ownership report for Jonathan M Nugent. You might contact Jonathan M Nugent via mailing address: 2190 Parkway Lake Dr, Birmingham Al 35244.

Discussions on Jonathan M Nugent

No discussions yet.